Venture-Backed Imara Primes $76M IPO Amid Volatile Market
Imara Inc., a venture-backed biotechnology company developing therapies for rare genetic disorders, on Tuesday set a price range on an estimated $76 million initial public offering, making it one of the...To view the full article, register now.
Already a subscriber? Click here to view full article